(Q42244281)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6230463%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6230463%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Methotrexate in the Treatment of Metastatic and Recurrent Primary Transitional Cell Carcinoma (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)50459-0

2 September 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)50459-0

2 September 2023

author name string

R. T. Oliver

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6230463

2 September 2023

H. R. England

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6230463

2 September 2023

R. A. Risdon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6230463

2 September 2023

J. P. Blandy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6230463

2 September 2023

language of work or name

English

0 references

publication date

1 March 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6230463%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 October 2019

https://api.elsevier.com/content/article/PII:S0022534717504590?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)50459-0

https://api.elsevier.com/content/article/PII:S0022534717504590?httpAccept=text/plain

2 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)50459-0

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2950459-0

2 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)50459-0

2 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6230463%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6230463%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

483-485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6230463%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6230463%20AND%20SRC:MED&resulttype=core&format=json

Metastasis results from preexisting variant cells within a malignant tumor

29 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)50459-0

Methotrexate treatment for advanced bladder cancer

2 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)50459-0

A phase 2 study of Cis-platinum in patients with recurrent bladder carcinoma. The London and Oxford Co-operative Urological Cancer Group

2 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)50459-0

Management of bladder cancer

2 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)50459-0

Methotrexate as salvage or adjunctive therapy for primary invasive carcinoma of the bladder

2 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)50459-0

2 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6230463%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference